Talis Biomedical
Menlo Park
About Talis Biomedical
Talis is dedicated to transforming diagnostic testing by developing and commercializing innovative products that are designed to enable accurate, low cost and rapid molecular testing for infectious diseases at the point-of-care. The company is developing the Talis One platform, a compact, sample-to-answer, cloud-enabled, molecular diagnostic platform.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $8.6M
- Funding stage: IPO
- Last round: Grant (May 2018)
- Ticker: nasdaq:TLIS
- Website: talisbio.com
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/talis-biomedical-93759 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.